Target intelligence / Profile preview

Tumor protein p53 R248Q mutant (TP53 R248Q)

Target
TP53 R248Q
Molecular classification
Transcription factor, Tumor suppressor, DNA-binding protein
01

Overview

TP53 R248Q mutation is a hotspot missense mutation in the DNA-binding domain of the tumor protein p53, replacing arginine at codon 248 with glutamine. This mutation impairs the ability of p53 to bind its canonical DNA consensus sequence, disabling its normal tumor suppressive activities (cell cycle arrest, apoptosis, senescence). In many cancers, the R248Q mutant protein acquires gain-of-function properties (promoting invasion, altering cell adhesion, supporting tumor progression). R248Q is classified as a DNA-contact mutation, distinctly impairing DNA recognition but often preserving overall protein conformation, and is one of the most frequently observed p53 mutant alleles in human tumors. Therapeutic strategies are under active development to target tumors that depend on mutant p53, including agents that restore wild-type activity or specifically degrade the mutant protein.

Other names
p53 R248Qmutant p53 R248QTP53 hotspot mutation R248Qp53 DNA contact mutant
02

Mechanism of action

Restoration of wild-type p53 function; Targeted degradation of mutant p53; Synthetic lethality with mutant p53; Inhibition of mutant p53 gain-of-function activities; Re-sensitization of cancer cells to apoptosis

03

Biological functions

Cell cycle regulationApoptosisDNA repairCellular senescenceTranscriptional regulation
04

Disease associations

Cancer, particularly solid tumors (lung, breast, colon, etc.)Li-Fraumeni syndrome (germline context)
05

Safety considerations

Tumor heterogeneitydominant-negative and gain-of-function effectspotential emergence of resistanceon-target toxicity in normal p53-mutant tissuesre-activation of mutant p53 may unpredictably affect non-tumor cells
06

Interacting drugs

APR-246 (Eprenetapopt)

4 more in the full profile.

07

Biomarkers

Presence of TP53 R248Q mutation by sequencingloss of wild-type p53 functionmutant p53 protein accumulation (detected by IHC)

Beyond the preview

Go deeper on Tumor protein p53 R248Q mutant (TP53 R248Q).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor protein p53 R248Q mutant (TP53 R248Q).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call